India, Aug. 29 -- The Maharashtra FDA on Saturday withdrew its order to cancel the drug sale licence of Cipla Pharma & Life Sciences Ltd's Carry and Forwarding unit in Pune after the Bombay High Court pulled up the regulator for going "overboard" and behaving in a "high-handed" manner.

A bench of Acting Chief Justice Ravindra Ghuge and Justice Gautam Ankhad said the FDA has acted against the "principles of natural justice".

The FDA said it would withdraw the license cancellation order forthwith and issue a fresh show cause notice to the company, pursuant to which a reasoned order would be passed.

The Food and Drug Administration (FDA) had cancelled the drug sale licenses of Cipla Pharma & Life Sciences Ltd's carrying and forwarding fac...